Wontech to Enter Japan’s Medical Market, Acquiring Stake in Local Entity for 10.8 Billion Won

Wontech will acquire a stake in a local investment company for about 10.8 billion won as it seeks to enter Japan’s medical market.

Wontech said in a May 15 filing with the Data Analysis, Retrieval and Transfer System (DART) that it had decided to acquire 11,689 shares of Japan M&B Holdings Co., Ltd. for 10.8087 billion won.

After the acquisition, Wontech will hold a 7.79% stake. The acquisition price represents 6.87% of its equity capital of 157.37588 billion won.

The acquisition is intended to strengthen global business competitiveness by entering Japan’s medical market and securing a local network. The payment will be made in cash, with the full amount scheduled to be remitted in one payment on June 11, 2026.

Japan M&B Holdings, a newly established Japanese company whose main businesses are investment and asset management, was founded on Feb. 27, 2026. Its representative director is Hong-jae Oh.

The acquisition price was converted into won using the initial posted exchange rate on the date of the board resolution (May 8, 2026), at 100 yen to 924.69 won. Equity capital and total assets at the end of the most recent fiscal year are based on the consolidated financial statements as of the end of 2025.

The transaction is not subject to a filing with the Fair Trade Commission, and no put option agreement was signed.